Onderzoeker
Diederik De Cock
- Trefwoorden:Sociale gezondheidswetenschappen
Affiliaties
- Biostatistiek en medische informatica (Onderzoeksgroep)
Lid
Vanaf1 jun 2022 → Heden - Gezondheidswetenschappen (Departement)
Lid
Vanaf1 jun 2022 → Heden - Gezondheidswetenschappen (Departement)
Lid
Vanaf1 jun 2022 → 20 okt 2022
Publicaties
21 - 30 van 55
- Comment on(2021)
Auteurs: Patrick Verschueren, Veerle Stouten, René Westhovens, Diederik De Cock, Sofia Pazmino
Pagina's: e177-e178 - Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis(2021)
Auteurs: Sofia Pazmino, Annelies Boonen, Diederik De Cock, Veerle Stouten, Johan Joly, Delphine Bertrand, René Westhovens, Patrick Verschueren
Pagina's: 1-6 - EULAR recommendations for a core data set for pregnancy registries in rheumatology(2021)
Auteurs: Yvette Meissner, Rebecca Fischer-Betz, Laura Andreoli, Nathalie Costedoat-Chalumeau, Diederik De Cock, Radboud J E M Dolhain, Frauke Forger, Doreen Goll, Anna Molto, Catherine Nelson-Piercy, et al.
Pagina's: 49-56 - A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis(2020)
Auteurs: Diederik De Cock, L. Brants, Isaline Soenen, Sofia Pazmino, Daniel Bertrand, Veerle Stouten, R. Westhovens, P. Verschueren
Pagina's: 873-878 - Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs(2020)
Auteurs: Veerle Stouten, Stijn Michiels, René Westhovens, Diederik De Cock, Amy Belba, Sofia Pazmino, Kristien Van der Elst, Johan Joly, Patrick Verschueren
Pagina's: 2593-2601 - EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs(2020)
Auteurs: Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Jan Maarten Wit, et al.
Pagina's: 685-699 - One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment(2020)
Auteurs: Kristien Van der Elst, Patrick Verschueren, Diederik De Cock, A De Groef, Veerle Stouten, Sofia Pazmino, Johanna Vriezekolk, Johan Joly, , René Westhovens
- Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis(2020)
Auteurs: Sofia Pazmino, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren
Pagina's: 556-565 - The rheumatoid arthritis patient global assessment(2020)
Auteurs: Diederik De Cock, Joel Hirsh
Pagina's: 923-924 - Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis(2019)
Auteurs: Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Patrick Verschueren
Pagina's: 2284-2294